We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
First post but held for a few years
Any ideas . Guess outsourced ?
Agree Discoman, company does not expect to be profitable in the short term and they are not disclosing sales figures until financial statement in September.
There’s a choice either you trade on the news flow or hold as a long term investment as FUM build Eroxon gradually as a worldwide brand. CBD product also looks lucrative for the long term.
Anyone had a chance to skim through this mornings RNS?
I've gone through a few pages.
My overriding opinion is - not much cash left, all hopes are pinned on Eroxon.
As guessed earlier.
Recent reviewer.
I think the positives will just be delighted and move on with a better personal quality of life. Less inclined to review. Just be repeating customers is my bet.
"Wonder gel! EROXON IS A LIFE SAVER! This product really has helped me create a better bond with my partner. For a moment that's meant to be an amazing experience can sometimes feel stressful - however this gel has changed everything. I've just came to order my second pack and thought I'd leave a review. So sorry to read it's not worked for some men, however it's really effective for me and the cost for such an beautiful experience is nothing."
I too caught the advert on terrestrial tv. It was put together by Cooper consumer health. So will likely be used across Europe once Eroxon is launched officially in each country tagged with the relevant supplier.
I wouldnt be too concerned. Again just looked 100+ SOLD in the last 24hrs stated on the site. Thats been a regular. Probs returning customers who don't even review! I think we are all in for a very pleasant surprise sales wise.
That will do for me.
It would be good to know how long Boots have an exclusive for the product.
Once they do not then it will be impossible for customers or supposed customers to manipulate the reviews.
I hope the exclusive is not too long.
Levitate would be just as much fun.
Sorry typo.Should have been Levitra.59%.
Looking at the Boots reviews it’s very easy to become disappointed as there are more negative reviews than positive ones.FUM have never indicated that there is a positive outcome above 70% using Eroxon.
I looked at Superdrug’s website to read the reviews for Viagra.It makes very interesting reading.The site indicates the satisfaction rate for the 4 most popular ED tablets:
1.Viagra 65%
2.Cialis 62%
3. Levitate 59%
4.Spedra 47%.
Eroxon is clearly comparable with the above,plus no side effects and rapid onset.
Looks quite comprehensive, however, They cannot get their figures right. At the beginning the forecast for 2030 is over 4bill, yet at the end in the table, they state 2030 as 2,49bill which is only for 1 years growth at 8.5%. They should have gotten someone to read it first before uploading it. Makes one wonder if all the other figures need checking....lol
What is interesting is Levitra which seems to have an annual increase in market share from 2021 to 2027. What's so special about their product that it would appear to be gradually, year on year, cornering the market ?
Saw it on ITV earlier too. Only a short one but at least there's some decent promotion of the product.
This link gives a comprehensive look at the ED market and the main players by market share. And the projected sales per area of the globe. Futura Medical is listed as one of the companies (obviously not a main player yet but clearly on the radar). It is clear that this is a fiercely guarded and competitive market so to expect some dirty tactics from competitors would be normal. The market is set to keep growing until 2030 which is all in Eroxon’s favour.
https://www.skyquestt.com/report/erectile-dysfunction-market
KeepRelevant... are you serious? Mate, if you think this will only go to 50p feel free to sell when it gets to that.
Just seen an advert on skysports Main event for Eroxon. At least they are getting the product brand out there to the wider audience now. May not be news on here, however first time I have seen it advertised.
GLA
Boots have thrown their weight behind this product and shown absolute confidence. Anyone familiar with corporate marketing will appreciate that an advertising campaign has to gain many approvals before launch. Ratio of marketing revenue vs potential profit is the driver. This comes in addition to all the trial successes (including FDA) and Coopers due diligence. Anyone talking the sp down at this moment is probably looking for a low entry point. My tuppence only.
Product is now available across Europe via New Pharma and others. Just ordered some from them as I’m staying in France. Only 7 reviews so far, but mostly positive. Will give my honest opinion once tested. Boots must be selling thousands of packs per week, so could be in the tens of thousands across Europe. A trading update from FUM would be welcome.
Will yet drop back but news imminent
Bit surprised with your low expectations for the s/p keeprelevant. If Eroxon takes just 5% of market share of ED market revenues would be well over £100M resulting in a much higher company valuation. This will take time but even analysts predictions are much higher. Don’t think you understand the basic concept of a P/E ratio.
Mmmmmm agree to; an extent , but this ain't gonna be a £5 share
Needs to get launched in US and across Europe ...get some turnover in and then it's a sell if it gets back to 50p, it only has to get a relatively low take up to generate a decent worldwide turnover and then get out .
Hi Jack, your submission reads very honestly and with just enough detail, many thanks for that.
LTH since 2019. 182,000 shares between my brokerage account and my IRA. I've obviously been biting my nails since it hit market on Farmaline and Boots, reading the reviews. With all of the negative reviews, I couldn't help but wonder how many were honest and how many were by LBO/LiamBooth dummy accounts. Anxiety got the best of me and I paid the $76+ bootleg price on Amazon to find out myself. Here's my take:
The effect of the product is best analogous to Rogaine; it doesn't give you everything you dream of, but it definitely makes a noticeable difference. Rogaine users will understand the reference.
1. When they say in 10 minutes or less, they really do mean an almost 10 actual minutes... It was a little hot at first (not very), then cool (but also not very), then the tip felt slightly different for quite a bit, but no luck. After about 5 minutes I was sweating bullets that it was a dud. Then around 7-8 minutes+ I experienced a "filling up" up top. Not overly-dramatic like an overdose amount of blue pill, but very real just the same.
2. I stayed "full from tippy top to bottom" all the way to finish. When things aren't going well I'll suffer from "halfies." No "halfies" here. We had our fun for 9-10 minutes until there was a happy end to the story, and I was pleased there was no struggle to "finish the act".
3. Zero side effects. Absolutely zero. I think it's the total lack of side effects that fools some users into not letting it work. The pills leave me with throbbing headaches, nausea, and back pain; and a terrible hangover the next day. With this, after finishing, I had to wonder if I had done anything new at all. Nothing left over to "mark the occasion" a especially different in any way, other than it was a successful attempt. That, plus the fact that the results were better but not unrealistic may not be enough for the blue pillers who are really hoping for that 4-hour war hammer they see on certain types of internet videos.
4. Because of all of the above, my personal take is that this may not totally displace the blue pill, but will settle into its own segment of the population who hate the side effects of its competitors. 25% market share give or take isn't bad tho. I'll take it and run with it.
Long live Petroc the Proven
Futura profit. ? £250000 £500000?
All progressing as conveyed.
Just my estimate entirely.
Boots min of 100 a day as website keeps telling me 100 PLUS SOLD in last 24 hrs.
£1 million in sales per yr min.
Futura profit. ? £25000 £50000?
Get into supermakets etc.
Fda Approval
BOOM!
Strap in for the ride. Fasten your seatbelts.
Its happening.